About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Michigan | 20,089 Studies Near You

Clinical TrialsMichigan

Clinical Trials in Michigan

Discover 20,089 clinical trials near Michigan. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 20,089 trials

TerminatedStudy to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) PatientsRociletinib is a novel, potent, small molecule irreversible tyrosine kinase inhibitor (TKI) that selectively targets mutant forms of the epidermal growth factor receptor (EGFR)…NCT01526928·Duarte, California and 48 others

Find Trials by Condition in Michigan

Breast Cancerin Michigan Lung Cancerin Michigan Prostate Cancerin Michigan Colorectal Cancerin Michigan Melanomain Michigan Leukemiain Michigan Lymphomain Michigan Pancreatic Cancerin Michigan Ovarian Cancerin Michigan Brain Cancerin Michigan Diabetes

Data from ClinicalTrials.govTerms

CompletedA Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular AlterationsPhase 1 and 2 trial to study the safety, pharmacokinetics, pharmacodynamics, patient reported outcomes and efficacy of PF-06463922 in ALK + advanced non-small cell lung cancer…NCT01970865·Fayetteville, Arkansas and 76 others

CompletedIntravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)This study was conducted in two parts; Part A and Part B: Part B was initially planned to include two cohorts.NCT01527500·Phoenix, Arizona and 18 others

RecruitingA Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell LymphomaThe purpose of this study is to evaluate the efficacy of glofitamab monotherapy compared with an investigator's choice of either rituximab plus bendamustine (BR), or lenalidomide…NCT06084936·Berkeley, California and 82 others

CompletedAortic Valve Replacement With Trifecta(TM)To confirm the clinical safety and effectiveness of the Trifecta valve.NCT00475709·Los Angeles, California and 17 others

TerminatedA Study of APTO-253 in Patients With Relapsed or Refractory AML or MDSThis study is being done to evaluate the safety and effectiveness of APTO-253 for the treatment of patients with the condition of acute myelogenous leukemia (AML) or…NCT02267863·Tucson, Arizona and 12 others

CompletedStudy Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic FailureThis study is a 48-week study to evaluate the efficacy and safety of an investigational regimen combining FDA approved HIV drugs in antiretroviral-experienced subjects failing on…NCT00038506·Los Angeles, California and 26 others

CompletedGemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast CancerTo determine how long Gemcitabine and Bevacizumab will stop the cancer from growing in patients with advanced breast cancer.NCT00623233·Fayetteville, Arkansas and 15 others

RecruitingA Study Assessing HMB-002 in Participants With Von Willebrand DiseaseThis is a first-in-human (FIH), Phase 1/2, 3-part open-label, dose escalation, safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD), and efficacy study evaluating…NCT06754852·Phoenix, Arizona and 24 others

CompletedEvaluation of WIRION™ EPS in Lower Extremities ArteriesDemonstrate the safety and performance of the WIRION™ EPS in subjects undergoing lower extremity atherectomy for the treatment of Peripheral Arterial Disease (PAD)NCT02780349·Denver, Colorado and 9 others

CompletedEfficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.The purpose of this study is to demonstrate that the efficacy of the combination product QVA149 is similar to the efficacy of the combination product umeclidinium/vilanterol on a…NCT02487498·Anaheim, California and 52 others

CompletedA Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid ArthritisThis study will investigate the safety and efficacy of an investigational drug, PF-04171327 on the signs and symptoms of rheumatoid arthritis in patients that require…NCT00938587·Anniston, Alabama and 40 others

CompletedRESTART C0168Z05 Rheumatoid Arthritis StudyThe purpose of this study is to assess the effectiveness of treatment in patients with active rheumatoid arthritis who are having an inadequate response to at least 3 months of…NCT00714493·Huntsville, Alabama and 75 others

CompletedA Pharmacokinetic (PK) and Pharmacodynamic (PD) Dose-ranging Phase II Study of Ticagrelor in Paediatric Patients With Sickle Cell DiseaseThe purpose of this Phase II dose-ranging study is to investigate pharmacokinetic (PK) and pharmacodynamic (PD) properties of various doses of ticagrelor followed by 4 weeks of…NCT02214121·Orange, California and 17 others

CompletedOptimizing Prevention of Healthcare-Acquired Infections After Cardiac SurgeryOur Aim is to identify patient risk factors and clinical practices associated with healthcare-acquired infections (HAIs) after cardiac surgery.NCT02068716·Ann Arbor, Michigan

CompletedA Study of CIN-107 in Adults With Primary AldosteronismThis is a multicenter, open-label study in adult patients with PA to evaluate the effectiveness and safety of CIN-107 after up to 12 weeks of treatment (Part 1), and then for…NCT04605549·Greenbrae, California and 9 others

TerminatedEfficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative ColitisPrimary Objective: To assess the efficacy of SAR339658 Secondary Objective: To assess the safety of SAR339658NCT01659138·Sun City, Arizona and 40 others

CompletedGS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) InfectionThe purpose of this phase 2 study is to determine whether 30 mg or 90 mg of GS-5885 when given with GS-9451, Tegobuvir and Ribavirin (RBV) for 12 or 24 weeks is effective, safe…NCT01353248·Birmingham, Alabama and 42 others

CompletedA Global Study to Assess the Effects of MEDI4736 (Durvalumab), Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung CancerThis study is a Phase III, randomised, open label, multi-centre study assessing the efficacy and safety of MEDI4736 (durvalumab) versus Standard of Care in NSCLC patients with…NCT02352948·Chandler, Arizona and 200 others

CompletedTralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)Primary objective: To evaluate the efficacy of tralokinumab compared with placebo in treating moderate to severe atopic dermatitis (AD).NCT03131648·Birmingham, Alabama and 122 others

Page 1 of 1005Next

in Michigan

Heart Diseasein Michigan